Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where WooYoung Choi is active.

Publication


Featured researches published by WooYoung Choi.


Virology Journal | 2010

Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005

Seok-Min Yun; Jung Eun Cho; Young-Ran Ju; Su Yeon Kim; Jungsang Ryou; Myung Guk Han; WooYoung Choi; Young Eui Jeong

We sequenced the envelope (E) gene of 17 strains of the Japanese encephalitis virus (JEV) isolated in South Korea in 1983-2005 and compared the sequences with those from previously reported strains. Our results show the remarkable genetic stability of the E gene sequence in Korean JEV strains. Five pairs of E gene sequences from 10 Korean strains were identical, despite geographical differences and a maximum five-year time span. Sequence comparisons with other Asian strains revealed that the Korean strains are closely related to those from China, Japan, and Vietnam. Genotype 3 strains were predominant in Korea before 1993, when genotype 1 strain K93A07 was first isolated. The two genotypes were detected simultaneously in 1994 but since then, only genotype 1 has been isolated in South Korea. Thus, the genotype change occurred according to the year of isolation rather than the geographical origin.


Clinical Infectious Diseases | 2015

Nosocomial Transmission of Severe Fever With Thrombocytopenia Syndrome in Korea

Won Young Kim; WooYoung Choi; Sun-Whan Park; Eun Byeol Wang; Won-Ja Lee; Youngmee Jee; Kyoung Soo Lim; Hyung-Jung Lee; Sun-Mi Kim; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Jun Hee Woo; Sung-Han Kim

Of the 27 healthcare workers (HCWs) who had contact with a fatally ill patient with severe thrombocytopenia syndrome in Korea (SFTS), 4 who were involved in cardiopulmonary resuscitation complained of fever and were diagnosed with SFTS via seroconversion. Exposure to respiratory secretions, blood, or gowns soiled by body fluids was significantly associated with infection of HCWs.


Virus Genes | 2003

Expression of Interferon Inducible Genes Following Hantaan Virus Infection as a Mechanism of Resistance in A549 Cells

Jae-Hwan Nam; Kyung-A Hwang; Cheong-Hee Yu; Tae-Hoon Kang; Jae-Young Shin; WooYoung Choi; In-Beom Kim; Young-Ran Joo; Hae-Wol Cho; Keun-Yong Park

Hantaan virus (HTN) is a causative agent of hemorrhagic fever with renal syndrome (HFRS). Little is known of its pathogenesis or the molecular mechanisms underlying resistance to HTN infection. In the present study, DNA microarray technology was used to monitor changes in mRNA levels after HTN infection, to elucidate resistance mechanisms to viral infection by understanding virus–host interactions. We found that several interferon (IFN)-inducible genes were up-regulated in host cells infected with HTN. According to previous available data, IFNs have been reported to be inhibitory, but their mode of action has not been yet clear. In this study, the 2′,5′-oligoadenylated synthetase (OAS) and Mx1 genes, not a double-stranded RNA-dependent protein kinase R (PKR), of the IFN response pathways are associated with antiviral activity during HTN infection. Furthermore, A549 cells treated with IFN-α were protected against HTN infection. Taken together, these results confirmed that IFN plays a role in cellular defenses against HTN infection at an early stage of the infection and revealed the resistance mechanism for HTN infection.


Antiviral Research | 2009

Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009

WooYoung Choi; Su-Jin Kim; Nam-Joo Lee; Meehwa Kwon; Inseok Yang; Min-Ji Kim; Seul-Gi Cheong; Donghyok Kwon; Joo-Yeon Lee; Hee-Bok Oh; Chun Kang

To investigate the frequency of amantadine resistance among influenza A viruses isolated in Korea during the 2003-2009 seasons, 369 (16.8%) 2199 A/H1N1 viruses and 780 (14.8%) of 5263 A/H3N2 viruses were randomly selected. The M2 and HA1 genes of each isolate were amplified by reverse transcription-polymerase chain reaction and followed by nucleotide sequencing. The results showed that the resistance rate to amantadine among A/H1N1 viruses increased significantly from 2004-2005 (33.3%) to 2007-2008 (97.8%) and then decreased dramatically in 2008-2009 (1.9%). The A/H1N1 isolates recently detected in 2008-2009 turned amantadine-sensitive containing two new substitutions at specific sites (S141N, G185A) in HA1. Compared with A/H1N1 viruses, the amantadine resistance among the A/H3N2 viruses increased from 2003-2004 (9.7%) to 2005-2006 (96.7%) and decreased in 2006-2007 (57.4%). During 2006-2007, both of amantadine-resistant and -sensitive A/H3N2 viruses co-circulated but clustered in different branches phylogenetically. All of A/H3N2 isolates tested during 2007-2009 appeared to cluster in the same group being resistant to amantadine.


Clinical and Experimental Vaccine Research | 2015

Progress of vaccine and drug development for Ebola preparedness.

WooYoung Choi; Kee-Jong Hong; Joo Eun Hong; Won-Ja Lee

Since the first case of Ebola virus disease (EVD) in Guinea was reported in March 2014 by World Health Organization (WHO), the outbreak has continued through the year and the total number of 19,065 patients was reported as the confirmed or suspected in the EVD-affected countries. Among the cases, 7,388 patients were reported death by 19 December. Currently, available therapeutics to treat the infected patients or vaccines to prevent people from infection is not developed yet while viral diagnostic methods were already developed and firmly established in a lot of countries as a first step for the preparedness of Ebola outbreak. Some potential therapeutic materials including ZMapp were supplied and the treated people got over the EVD. Several candidates of vaccines also were investigated their efficacy in animal models by National Institute of Health (NIH) and Department of Defense, and they are processing of clinical tests in West Africa aiming to finish the development by the 2015. Vaccine and therapeutic development is essential to stop the EVD outbreak in West Africa, also to protect the world from the risk which can be generated by potential spread of Ebola virus.


Emerging Infectious Diseases | 2010

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, South Korea

Hwajung Yi; Joo-Yeon Lee; Eun-Hye Hong; Mi-Seon Kim; Donghyok Kwon; Jang-Hoon Choi; WooYoung Choi; Kisoon Kim; Jong-Koo Lee; Hee-Bok Oh; Chun Kang

To identify oseltamivir resistance, we analyzed neuraminidase H275Y mutations in samples from 10 patients infected with pandemic (H1N1) 2009 virus in South Korea who had influenza that was refractory to antiviral treatment with this drug. A neuraminidase I117M mutation that might influence oseltamivir susceptibility was detected in sequential specimens from 1 patient.


Emerging Infectious Diseases | 2013

Accuracy of Diagnostic Methods and Surveillance Sensitivity for Human Enterovirus, South Korea, 1999–2011

Ji-Yeon Hyeon; Seoyeon Hwang; Hyejin Kim; Jae-Hyoung Song; Jeongbae Ahn; Byunghak Kang; Kisoon Kim; WooYoung Choi; Jae Keun Chung; Cheon-Hyun Kim; Kyungsoon Cho; Youngmee Jee; Jong Hyun Kim; Kisang Kim; Sun-Hee Kim; Min Ji Kim; Doo-Sung Cheon

The epidemiology of enteroviral infection in South Korea during 1999–2011 chronicles nationwide outbreaks and changing detection and subtyping methods used over the 13-year period. Of 14,657 patients whose samples were tested, 4,762 (32.5%) samples were positive for human enterovirus (human EV); as diagnostic methods improved, the rate of positive results increased. A seasonal trend of outbreaks was documented. Genotypes enterovirus 71, echovirus 30, coxsackievirus B5, enterovirus 6, and coxsackievirus B2 were the most common genotypes identified. Accurate test results correlated clinical syndromes to enterovirus genotypes: aseptic meningitis to echovirus 30, enterovirus 6, and coxsackievirus B5; hand, foot and mouth disease to coxsackievirus A16; and hand, foot and mouth disease with neurologic complications to enterovirus 71. There are currently no treatments specific to human EV infections; surveillance of enterovirus infections such as this study provides may assist with evaluating the need to research and develop treatments for infections caused by virulent human EV genotypes.


Osong public health and research perspectives | 2012

Prevalence of Tick-Borne Encephalitis Virus in Ixodid Ticks Collected from the Republic of Korea During 2011–2012

Seok-Min Yun; Bong Gu Song; WooYoung Choi; Won Il Park; Sung Yun Kim; Jong Yul Roh; Jungsang Ryou; Young Ran Ju; Chan Park; E-Hyun Shin

Objectives In this study, we demonstrated that TBEV-infected ticks have been distributed in the ROK, combined with our previous results. These results suggest that TBEV may exist in the ROK, and H. longicornis, H. flava, and I. nipponensis may be potential vectors of TBEV. In addition, these results emphasize the need for further epidemiological research of TBEV. Methods We examined for the presence of RNA of TBEV by reverse transcriptase-nested polymerase chain reaction (RT-nested PCR) using ixodid ticks captured in 25 localities of 10 provinces. Ticks were collected by the flagging and dragging method or using sentinel BG traps at forests, grass thickets, and grassland. A total of 13,053 ticks belonging to two genera and four species were collected and pooled (1292 pools), according to collection site, species of tick, and developmental stage. Results Among 1292 pools, the envelope (E) protein gene of TBEV was detected using RT-nested PCR in 10 pools (3 pools of the 1,331 adult ticks and 7 pools of the 11,169 nymph ticks) collected from Gangwon-do province, Jeonrabuk-do province, and Jeju Island. The minimum infection rates for TBEV of Haemaphysalis longicornis, Haemaphysalis flava, and Ixodes nipponensis were 0.06%, 0.17%, and 2.38%, respectively. Phylogenetic analysis based on the partial E protein gene was performed to identify relationships between the TBEV strains. This showed that 10 Korean strains clustered with the Western subtype. Conclusion In this study, we investigated the prevalence of tick-borne encephalitis virus (TBEV) in ixodid ticks from various regions of the Republic of Korea (ROK) during 2011–2012 to identify whether TBEV is circulating and to determine the endemic regions of TBEV.


Emerging Infectious Diseases | 2012

Avian influenza a (H5N1) virus antibodies in poultry cullers, South Korea, 2003-2004.

Donghyok Kwon; Joo-Yeon Lee; WooYoung Choi; Jang-Hoon Choi; Yoon-Seok Chung; Nam-Joo Lee; Hyang-Min Cheong; Jacqueline M. Katz; Hee-Bok Oh; Hae-Wol Cho; Chun Kang

Transmission of influenza (H5N1) virus from birds to humans is a serious public health threat. In South Korea, serologic investigation among 2,512 poultry workers exposed during December 2003–March 2004 to poultry with confirmed or suspected influenza (H5N1) virus infection found antibodies in 9. Frequency of bird-to-human transmission was low.


Vector-borne and Zoonotic Diseases | 2016

First Isolation of Severe Fever with Thrombocytopenia Syndrome Virus from Haemaphysalis longicornis Ticks Collected in Severe Fever with Thrombocytopenia Syndrome Outbreak Areas in the Republic of Korea

Seok-Min Yun; Bong Gu Song; WooYoung Choi; Jong Yul Roh; Ye-Ji Lee; Won Il Park; Myung Guk Han; Young Ran Ju; Won-Ja Lee

Abstract Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne infectious disease that is endemic to China, Japan, and the Republic of Korea (ROK). In this study, 8313 ticks collected from SFTS outbreak areas in the ROK in 2013 were used to detect the SFTS virus (SFTSV). A single SFTSV was isolated in cell culture from one pool of Haemaphysalis longicornis ticks collected from Samcheok-si, Gangwon Province, in the ROK. Phylogenetic analysis showed that the SFTSV isolate was clustered with the SFTSV strain from Japan, which was isolated from humans. To the best of our knowledge, this is the first isolation in the world of SFTSV in ticks collected from vegetation.

Collaboration


Dive into the WooYoung Choi's collaboration.

Top Co-Authors

Avatar

Won-Ja Lee

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Sun-Whan Park

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Youngmee Jee

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Chun Kang

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Seok-Min Yun

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Hae-Wol Cho

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Joo-Yeon Lee

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Ye-Ji Lee

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kisoon Kim

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge